The Management Committee of the Eurasian Affiliate of ISPE held its first meeting on March 14, 2017.
The Management Committee includes the representatives of FBI SID&GP, JSC National Immunobiological Company, CJSC Biocad, LLC Nanolec, LLC GEROPHARM, JSC R-Pharm, OJSC Biokhimik, OJSC Akrikhin, CJSC Active Component, FAVEA Group, Pharmcontract Group of Companies, JSC Generium, OJSC Nizhpharm, and PJSC Pharmstandard.
A.N. Sharonov (FBI SID&GP) was nominated as the candidate for chairman of the Management Committee. His candidacy will be submitted for approval to ISPE 2017 Europe Annual Meeting that will be held in Barcelona in April.
The Eurasian Affiliate of ISPE will be officially opened in the fall of 2017 and prior to this event the Management Committee and members of the working group will have to complete many tasks, including the registration of the legal entity “The Society for Pharmaceutical Engineering. Eurasian Affiliate of ISPE,” elaborate the policy, goals and strategy of the Eurasian Affiliate of ISPE, develop and adapt the procedure of the main affiliate of ISPE, prepare and approve the business plan and financial plan for 2018-2020, and other.
The establishment of ISPE Affiliate for the Eurasian Economic Union and CIS is viewed as a resource that offers for professionals of the pharmaceutical industry the opportunity to communicate in one language, meet face to face with colleagues, participate in various events together with members of ISPE.